David Whitney, DPM
NPI 1073690285 · Primary Podiatric Medicine Podiatrist · Falmouth, MA
Enrolled with Medicare as Practitioner - Podiatry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1073690285
- Entity type
- Individual
- Primary specialty
- Primary Podiatric Medicine PodiatristPodiatric Medicine & Surgery Service Providers
- Credential
- DPM
- Sex
- Male
- Sole proprietor
- No
- License
- 1834 (MA)
Specialties & taxonomies
Podiatric Medicine & Surgery Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
11,303 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Removal of Fingernails Or Toenails, 1-5 Nails11720 | 4,524 | $33 |
| Removal of Noncancer Thickened Skin Growth, 2-4 Growths11056 | 3,800 | $29 |
| Removal of Noncancer Thickened Skin Growth, 1 Growth11055 | 643 | $24 |
| Removal of Fingernails Or Toenails, 1-5 Nails11720 | 432 | $14 |
| Removal of Fingernails Or Toenails, 6 Or More Nails11721 | 425 | $45 |
| Removal of Noncancer Thickened Skin Growth, 2-4 Growths11056 | 415 | $21 |
| Removal of Noncancer Thickened Skin Growth, More Than 4 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 2 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Cephalexin | 23 | 21 |
| Methylprednisolone | 12 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-11-01
- Last updated
- 2008-02-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.